Acrivon Therapeutics ACRV
NASDAQ ACRV
$1.83 +0.03 (+1.67%)
At close: Oct 21, 2026 · 4:00 PM EDT

Acrivon Therapeutics (ACRV) Common Stock Issued (2022 - 2026)

Updated

Analysis

Acrivon Therapeutics (ACRV) Common Stock Issued (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 359.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 9.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Acrivon Therapeutics 76.78 Mn -358.75 Mn - 7.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.31 Mn
Mar 31, 2025 1,000.00
Jun 30, 2024 130.01 Mn
Mar 31, 2024 79,000.00
Dec 31, 2023 318,000.00
Sep 30, 2023 78,000.00
Dec 31, 2022 104.46 Mn
API Access

Acrivon Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ACRV&period=max&api_key=YOUR_API_KEY